SEC 13F Intelligence

Schroder Investment Management Group / PFE

Schroder Investment Management Group’s Pfizer Inc Position

Does Schroder Investment Management Group own Pfizer Inc (PFE)? Yes — 12.60M shares worth $354M (+0.29% of its 13F portfolio) as of Q1 2026, up from 12.35M shares the prior filed quarter.

Position Value
$354M
Q1 2026
Shares
12.60M
% of Portfolio
+0.29%
Quarters Held
30
currently held

Position History PFE

Reported value by quarter
Q4 ’18: $433MQ4 ’18Q1 ’19: $434MQ2 ’19: $397MQ3 ’19: $350MQ4 ’19: $353MQ4 ’19Q1 ’20: $220MQ2 ’20: $152MQ3 ’20: $313MQ4 ’20: $512MQ4 ’20Q1 ’21: $329MQ2 ’21: $359MQ3 ’21: $386MQ4 ’21: $622MQ4 ’21Q1 ’22: $611MQ2 ’22: $622MQ3 ’22: $462MQ4 ’22: $509MQ4 ’22Q1 ’23: $284MQ2 ’23: $230MQ3 ’23: $164MQ4 ’23: $163MQ4 ’23Q1 ’24: $171MQ2 ’24: $201MQ3 ’24: $254MQ4 ’24: $265MQ4 ’24Q1 ’25: $263MQ2 ’25: $305MQ3 ’25: $315MQ4 ’25: $308MQ4 ’25Q1 ’26: $354Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202612.60M$354M+0.29%
Q4 202512.35M$308M+0.23%
Q3 202512.38M$315M+0.25%
Q2 202512.58M$305M+0.26%
Q1 202510.37M$263M+0.27%
Q4 20249.97M$265M+0.25%
Q3 20248.78M$254M+0.26%
Q2 20247.17M$201M+0.22%
Q1 20246.17M$171M+0.20%
Q4 20235.65M$163M+0.21%
Q3 20234.95M$164M+0.24%
Q2 20236.26M$230M+0.33%
Q1 20236.97M$284M+0.42%
Q4 20229.93M$509M+0.81%
Q3 202210.55M$462M+0.76%
Q2 202211.86M$622M+0.95%
Q1 202211.81M$611M+0.81%
Q4 202110.54M$622M+0.81%
Q3 20218.97M$386M+0.59%
Q2 20219.17M$359M+0.45%
Q1 20219.09M$329M+0.43%
Q4 202013.91M$512M+0.36%
Q3 20208.61M$313M+0.50%
Q2 20204.65M$152M+0.28%
Q1 20206.37M$220M+0.47%
Q4 20199.01M$353M+0.57%
Q3 20199.66M$350M+0.62%
Q2 20199.15M$397M+0.72%
Q1 201910.22M$434M+0.77%
Q4 20189.91M$433M+0.78%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Schroder Investment Management Group’s full portfolio or all institutional holders of PFE.